Pfizer Expands Recall to All Lots of Chantix Due to Nitrosamine Impurity
The recalled lots of Chantix were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from May 2019 to September 2021.
Poisoning & Drug Dependence
FDA: Mandatory Opioid Prescriber Education to Be Discussed at Upcoming Workshop
Overall opioid overdoses and opioid-involved deaths continue to increase.
FDA Issues Marketing Denial Orders for Flavored E-Cigarette Products
The MDOs were issued to approximately 55,000 flavored ENDS products from JD Nova Group LLC, Great American Vapes, and Vapor Salon and included favors such as Apple Crumble, Dr. Cola and Cinnamon Toast Cereal.
FDA Takes Steps to Maintain Supply of Smoking Cessation Therapy
N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
Chantix Recalled, Distribution Halted Over Nitrosamine Impurity
Long-term use of a product containing N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
- Loading...
Loading...
Next post in News
Loading... 
Loading...